The estimated Net Worth of Susan E Burwig is at least $43.2 Millón dollars as of 5 August 2024. Ms. Burwig owns over 50,000 units of Medpace Inc stock worth over $19,237,775 and over the last 8 years she sold MEDP stock worth over $21,498,217. In addition, she makes $2,429,460 as Executive Vice President - Operations at Medpace Inc.
Susan has made over 14 trades of the Medpace Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently she exercised 50,000 units of MEDP stock worth $4,532,500 on 5 August 2024.
The largest trade she's ever made was selling 62,222 units of Medpace Inc stock on 2 September 2021 worth over $11,960,313. On average, Susan trades about 10,555 units every 127 days since 2016. As of 5 August 2024 she still owns at least 57,500 units of Medpace Inc stock.
You can see the complete history of Ms. Burwig stock trades at the bottom of the page.
Susan E. Burwig serves as Executive Vice President - Operations of the Company. She joined Medpace in August 1993 and has served in various key leadership roles within the Clinical Operations department. From February 2003 to May 2015, Ms. Burwig served as Senior Vice President, Clinical Operations, overseeing clinical trial management, clinical monitoring, start-up, including feasibility, and new business proposals. In June 2015, Ms. Burwig was appointed Senior Vice President, Operations, and in January 2017 she was named as Executive Vice President, Operations. Prior to joining Medpace, Ms. Burwig held several clinical roles, including leading heart failure clinical research studies at the University of Cincinnati. Ms. Burwig received her Bachelor of Science in Nursing as well as an MA in Sports Administration from Kent State University.
As the Executive Vice President - Operations of Medpace Inc, the total compensation of Susan Burwig at Medpace Inc is $2,429,460. There are 1 executives at Medpace Inc getting paid more, with August Troendle having the highest compensation of $7,712,840.
Susan Burwig is 57, she's been the Executive Vice President - Operations of Medpace Inc since 2017. There are 7 older and 7 younger executives at Medpace Inc. The oldest executive at Medpace Holdings Inc is Fred Davenport, 68, who is the Lead Independent Director.
Susan's mailing address filed with the SEC is C/O MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI, OH, 45227.
Over the last 8 years, insiders at Medpace Inc have traded over $3,140,136,825 worth of Medpace Inc stock and bought 2,899,276 units worth $330,034,155 . The most active insiders traders include Limited Partnership Medpace..., August J. Troendle y Investors, Llc Medpace. On average, Medpace Inc executives and independent directors trade stock every 9 days with the average trade being worth of $40,224,347. The most recent stock trade was executed by Robert O. Kraft on 22 August 2024, trading 8,127 units of MEDP stock currently worth $346,373.
a therapeutically focused leader in research-based drug development, medpace builds strong strategic partnerships with select sponsors to advance the most efficient and cost-effective path to drug approval. as a full service, global clinical research organization (cro), medpace sees itself as a steward of your drug, leveraging its extensive medical and regulatory expertise to deliver additional input, strategy, and efficiencies to each and every phase of the clinical trial. from custom solutions addressing the needs of small and midsize biotechnology companies to full-service offerings for global pharmaceutical companies, medpace has the breadth, depth, and flexibility to deliver a superior result, specific to your needs, on six continents.
Medpace Inc executives and other stock owners filed with the SEC include: